Bukowski Rm
Impact in
- Immunology top 5%
- Complement system in diseases
- Hematology top 5%
- Erythropoietin and Anemia Treatment
- Platelet Disorders and Treatments
Papers in
- Oncology 4
- Cutaneous Melanoma Detection and Management 1
-
- Complement system in diseases 3
- Co-authors
- Hewlett Js (7 shared papers)Carl W. Groppe (4 shared papers)Harris Jw (1 shared paper)Weick Jk (3 shared papers)Delvyn Caedren Case (1 shared paper)Richard T. Silver (1 shared paper)Craig R. Nichols (1 shared paper)J. W. Kugler (1 shared paper)
- Journals
- Blood (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)The Annals of Thoracic Surgery (1 paper)PubMed (18 papers)
- Partner nations
- United States
In The Last Decade
Bukowski Rm
22 papers receiving 747 citations
Peers
Comparison fields: 5 of 32
- Immunology 361
- Hematology 161
- Biochemistry 25
- Oncology 50
- Pulmonary and Respiratory Medicine 47
Countries citing papers authored by Bukowski Rm
This map shows the geographic impact of Bukowski Rm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bukowski Rm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bukowski Rm more than expected).
Fields of papers citing papers by Bukowski Rm
This network shows the impact of papers produced by Bukowski Rm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bukowski Rm. The network helps show where Bukowski Rm may publish in the future.
Co-authors
The 25 scholars most cited alongside Bukowski Rm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1977 | 213 | |
| 2 | 1993 | 172 | |
| 3 | Thrombotic thrombocytopenic purpura: a review. | 1982 | 125 |
| 4 | Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura. | 1976 | 114 |
| 5 | Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma. | 2000 | 43 |
| 6 | Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study. | 1981 | 35 |
| 7 | Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin. | 1979 | 32 |
| 8 | Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas. | 1980 | 28 |
| 9 | Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study. | 1982 | 17 |
| 10 | Treatment of severe aplastic anemia with antithymocyte globulin. | 1982 | 13 |
| 11 | Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma. | 1990 | 13 |
| 12 | 1995 | 13 | |
| 13 | 1983 | 11 | |
| 14 | Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study. | 1983 | 9 |
| 15 | Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study. | 1983 | 8 |
| 16 | Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer. | 1990 | 6 |
| 17 | Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin. | 1977 | 5 |
| 18 | Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study. | 1987 | 5 |
| 19 | Acute colonic pseudo-obstruction associated with interleukin-2 therapy. | 1991 | 4 |
| 20 | Biologic therapy in patients receiving salvage treatment. | 1994 | 3 |
About Bukowski Rm
Bukowski Rm is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Hepatology and Epidemiology, having authored 22 papers that have together received 873 indexed citations. Recurring topics across this work include Complement system in diseases (3 papers), Renal cell carcinoma treatment (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Gastric Cancer Management and Outcomes (1 paper), Cutaneous Melanoma Detection and Management (1 paper), Erythropoietin and Anemia Treatment (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Immunology (361 citations), Hematology (161 citations), Biochemistry (25 citations), Oncology (50 citations) and Pulmonary and Respiratory Medicine (47 citations). Bukowski Rm has collaborated with scholars based in United States. Frequent co-authors include Hewlett Js, Carl W. Groppe, Harris Jw, Weick Jk, Delvyn Caedren Case, Richard T. Silver, Craig R. Nichols, J. W. Kugler, Anna Maria Storniolo and Kay M. Larholt. Their work appears in journals such as Blood, Cancer Chemotherapy and Pharmacology, JNCI Journal of the National Cancer Institute, The Annals of Thoracic Surgery and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.